The University Of North Carolina At Chapel Hill — Chapel Hill, North Carolina

The University Of North Carolina At Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599-7235.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

The University Of North Carolina At Chapel Hill has participated in 4 clinical trials.

Therapeutic areas: Prostate Cancer, Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive.

Sponsors: Abbott, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University Of North Carolina At Chapel Hill?

The University Of North Carolina At Chapel Hill has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University Of North Carolina At Chapel Hill conducted?

The University Of North Carolina At Chapel Hill has 4 clinical trials on record. Their work covers Prostate Cancer, Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive.

Is The University Of North Carolina At Chapel Hill accredited by Crixeo Health?

The University Of North Carolina At Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University Of North Carolina At Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.